Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)

v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenues:    
License and collaborative fees $ 2,491 $ 263
Contract and other 1,471 2,388
Total revenues 3,962 2,651
Operating expenses:    
Research and development 13,610 20,004
Selling, general and administrative 4,305 5,220
Restructuring 36  
Total operating expenses 17,951 25,224
Loss from operations (13,989) (22,573)
Other income (expense):    
Interest expense (1,002) (1,115)
Other income (expense), net (306) 2,010
Revaluation of contingent warrant liabilities 6,932 (40)
Net loss $ (8,365) $ (21,718)
Basic and diluted net loss per share of common stock $ (0.07) $ (0.19)
Shares used in computing basic and diluted net loss per share of common stock 119,568 116,193
Other comprehensive loss:    
Net loss $ (8,365) $ (21,718)
Net unrealized loss on marketable securities (42)  
Comprehensive loss $ (8,407) $ (21,718)